Rhythm Pharmaceuticals
RYTM
RYTM
263 hedge funds and large institutions have $7.2B invested in Rhythm Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 57 funds opening new positions, 98 increasing their positions, 82 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
16% more funds holding
Funds holding: 227 → 263 (+36)
2.14% more ownership
Funds ownership: 104.59% → 106.73% (+2.1%)
0% more funds holding in top 10
Funds holding in top 10: 10 → 10 (0)
Holders
263
Holding in Top 10
10
Calls
$50.3M
Puts
$15.2M
Top Buyers
| 1 | +$142M | |
| 2 | +$92.7M | |
| 3 | +$60.4M | |
| 4 |
Jennison Associates
New York
|
+$41.6M |
| 5 |
JP Morgan Chase
New York
|
+$40.9M |
Top Sellers
| 1 | -$62.1M | |
| 2 | -$56.6M | |
| 3 | -$34.2M | |
| 4 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$31.1M |
| 5 |
CC
Checkpoint Capital
San Francisco,
California
|
-$29.9M |
